Loading

JSM Gastroenterology and Hepatology

Hypersecretion of Hydrochloric Acid as a Cause of Superior Mesenteric Artery Syndrome – Review

Review Article | Open Access
Article DOI :

  • 1. Department of Pediatric Radiology, Medical Center for Rehabilitation and Geriatrics, Israel
+ Show More - Show Less
Corresponding Authors
Department of Pediatric Radiology of the 1-st State Hospital, Minsk, Belarus, Dorot, Medical Center for Rehabilitation and Geriatrics, Netanya, Israel
INTRODUCTION

Currently, all authors of articles adhere to the hypothesis Professor Carl von Rokitansky (1842) that explains the presence of clinical and radiological symptoms of obstruction in the 3rd part of the duodenum, by its compression in the aortomesenteric angle (AMA). Therefore, this syndrome has received the name “Superior mesenteric artery syndrome” (SMAS). There are many contradictory statements in this hypothesis, which will be discussed below. To understand the pathological physiology of SMAS, it is necessary to focus on the normal physiology of the duodenum [1].

Duodenal motility

In the duodenum, from the pyloric sphincter (PS) of the stomach to the duodenojejunal junction, four sphincters function, which protects the small intestine from the aggressive effects of hydrochloric acid. If the bolus would pass through the duodenum as quickly as through the esophagus, then an extremely low pH bolus would cause irritation of the jejunum or, at best, a dumping syndrome [2].

The post bulbar sphincter (PBS), together with the pyloric sphincter (PS), provides evacuation of the chyme from the stomach as portions of a certain volume (Figure 1A). When the acid bolus reaches the Ochsner’s sphincter, which is in the 3rd part of the duodenum, it causes of its contraction, which prevents entering aggressive chyme to the jejunum (Figure 1B). As a result of the Ochsner’s sphincter contraction, the bolus is thrown cranially, but Kapanji’s sphincter contraction, it is again thrown to the Ochsner’s sphincter. This pendulum movement of the bolus between the Ochsner and Kapanji sphincters occurs several times. At this time, the chyme mixes with bile and pancreatic juice, which raise the pH of the chyme. When the pH reaches a level that is safe for the jejunum, Ochsner’s sphincter opens, and bolus passes into the jejunum [1,3].

The motility of the Ochsner’s sphincter is a periodic change of contraction and relaxation, depending on the pH of the bolus. Normally, radiologists cannot see a contraction of the Ochsner Sphincter works because they use an acid-free contrast agent. I have done research adding 3g Vitamin C to 200 ml of barium. The acid caused Ochsner’s sphincter to contract and this made possible to determine and measure of its length. It turned out that in length (3.20 ± 0.15 cm) and location it corresponds to the length (3.30 ± 0.15 cm) (P > 0.2) and location of the narrowing of the duodenum in the so-called SMAS [3].

Ochsner described in detail the functional sphincter in the 3rd part of the duodenum in 1906. During gallbladder and stomach operations he found “in many cases, the duodenum is distended with gas to a point just below the entrance of the common duct, while below this it is contracted, and upon raising the transverse colon and finding the origin of the jejunum, this portion of the intestine will also be found in a contracted condition. In all these specimens, there is also a marked thickening of the intestinal wall at a point 2 to 4 centimeters below the entrance of the common duct, and a careful study of this thickening demonstrated the presence of a marked increase in the circular muscle fibers. These facts pointed towards the presence of a sphincter at this point whose physiological function would consist in providing for a means of retaining the chyme in the upper portion of the duodenum sufficiently long to provide for thorough mixing with bile and pancreatic fluid”. Ochsner believed that “under certain forms of irritation or inflammation of the gallbladder or ducts, this duodenal sphincter had taken up an action”[4]. The 12 out of 14 patients described by Ochsner were diagnosed with gastric ulcer [4], duodenal ulcer [2], cholecystitis [7], chronic appendicitis [5], pancreatitis [7]. All patients had a dilated duodenum, and 6 of them had a gastric dilatation [4]. Kapanji’s sphincter and Ochsner’s sphincter are widely known in the scientific literature in French and Russian [5]. Oddi’s sphincter this is the only sphincter of the duodenum, which is described in the English-language literature. The pathology of this sphincter is closely related to the pathology of the bile and pancreatic ducts.

ANALYSIS OF THE VASCULAR HYPOTHESIS OF THE PATHOGENESIS OF SMAS

Analysis of radiological studies in the so-called SMAS

Ever since Professor Carl von Rokitansky (1842) advanced the vascular hypothesis it is believed that obstruction of the 3rd part of the duodenum is caused by intestinal compression in the aortomesenteric angle (AMA). The abdominal aorta is located near the middle of the vertebra (Figure 2a,b) Its width is approximately 2 cm, and the width of the superior mesenteric artery (SMA) is 0.5 cm. The length of the constriction that these vessels can create cannot exceed 1 cm. I measured the distance from proximal points the sharp contraction in the 3rd part of the duodenum to the location of the SMA, i.e., up to the middle of the 3rd lumbar vertebra (L-3) on 35 radiographs, CT, and MRI, published in PubMed and PMC. On radiographs, all the values are greater than the real ones. We calculated the true value by multiplying the value measured on the radiograph by the projection increase factor. It is equal to the ratio of the true height of the first lumbar vertebra (2.2 cm in adults) to the value of its image on the radiograph. When analyzing CT and MRI, the coefficient is equal to the ratio of the true diameter of the abdominal aorta (2 cm) to the value of its image on the scan. In 29 (83%) cases on X-ray examination or on CT and MRI, the length of the narrowed segment of the duodenum ranged from 2.5 to 4.6 cm (3.30 ± 0.15 cm) and always started a few centimeters to the right of L-3 (Figure 2 a-d) [1,3,6,7].

Only in 6 (17%) of 35 cases where the length of the narrowed segment of the could be measured, it looked short, since the place of obstruction was near the midline of the vertebra and its length was within 1 cm. However, as seen in Figure 2 e, the narrowed segment of the duodenum can be located to the left of the midline of the vertebra, which is confirmed by Ochsner’s observations during surgery. Secondly, the X-ray can show the moment opening of the Ochsner’s sphincter, which happens when there is high pressure above it (Figure 3).

Conclusion: Carl von Rokitansky proposed a vascular hypothesis for the pathogenesis of the so-called SMAS almost 200 years ago, when there were no radiological research methods that we use now. From the analysis of radiological studies, it follows that in all cases, the contraction of the Ochsner sphincter, and not the compression of the duodenum in the AMA, is the cause of the so called SMAS.

On the pathogenesis of the so-called SMAS

It is argued that the cause of the compression of the duodenum in the AMA is rapid weight loss and the disappearance of adipose tissue, which normally supposedly push the SMA away from the aorta [8]. This statement is hypothetical in nature, since, firstly, no evidence is provided to support this thesis. On the contrary, analysis of the literature does not support this claim. For example:

A) In a significant percentage of patients with SMAS, the mean body mass index (BMI) was within normal limits. In a series of 14 children, it was 21.3 kg/m² (range 13.3-30.4 kg/m²). The mean weight loss before diagnosis was 3.8 kg (range 0-20 kg). No weight loss was found in 50% of the patients [8].

B) Among patients with acute development of the disease, i.e., within 1 - 53 (8.2 ± 1.9) days, conservative treatment was successful after 2-59 (13.4 ± 2.9) days in 88.9% of patients. First, it is obvious that during this time the volume of adipose tissue in the AMA could not change significantly. Second, repeated CT after resolution of clinical symptoms did not reveal any changes in AMA [9].

?) If soft adipose tissue appears between the aorta and the SMA, then how does it can push forward the tense vessel and does not push back and squeeze more compliant duodenum?

What does the AMA value indicate?

A) All authors, referring to the article by Neri et al. [10], believe that the AMA value less than 25 ° is an important diagnostic feature of SMAS. However, the study, to which everyone refers, was carried out with numerous violations that do not allow us to consider its results reliable, that is, scientific. Studies with the AMA <25 ° were initially selected. No justification for the choice of this figure is provided. There are no characteristics of 50 healthy subjects (control group). The authors did not measure AMA for persons with different BMIs. Therefore, they had no reason to report normal boundaries at all. «The US detected reduced angles <25 ° in 29 of the 950 subjects (3.05%). X-ray with barium (Figure 4a) revealed compression on the third segment of the duodenum in 28 of 29 patients during the symptomatic period and in nine of 29 during the symptom-free interval» [10].

On the radiograph (Figure 4a), which Neri et al presented as the most demonstrative of 29, there are no signs of obstruction because neither the stomach nor the duodenum is dilated. Secondly, the narrowing that begins to the right of the vertebra has nothing to do with AMA. The contraction in the duodenal area corresponds to the normal function of the Ochsner sphincter. This is confirmed by a similar observation by Eisenberg [11]. Thus, this radiograph does not correspond to the concept of SMAS and as well as all the conclusions of the article by Neri et al it is a falsification of the facts for confirming the invented limit of the AMA norm - 25°.

In the article by Neri et al states: “The aortomesenteric angle is normally 25–60° {[2,3,6,7,10-12]} and the mean aortomesenteric distance of 10–28 mm {[1-3,6,7,10-12]}. Subjects presenting an angle <25° and aortomesenteric distance <8-10 mm may be affected by SMA syndrome” [10]. However, none of these references, AMA studies in healthy patients with different BMIs, like in the article by Neri et al., Moreover, most of the links are descriptions of isolated cases. This is false information, an indicator of the quality of the article. This lie had to confirm the reliability of the proposed parameters of the norm.

B) Bhagirath Desai et al. did a prospective study of 100 patients who had undergone CT scans for various other complaints. A strong positive correlation was found between BMI and the angle between the aorta and SMA. With BMI increase, the angle also increases. In 25% of patients, these rates were less than the norm [10]. In third world countries, there are hundreds of millions of people with low BMI which does not increase the SMAS frequency. Thus, the AMA value depends only on the amount of fat in the body.

Conclusion: 1) No one has researched the AMA value in healthy people of different ages and weights. 2) The value of AMA is proportional to BMI. 3) The statement that in AMA is <25° should be suspected of SMA, is the result of not conscientious research.

CLINICAL ANALYSIS OF 227 CASES OF SMAS

I have analyzed 79 articles from PubMed and PMC describing 227 cases of SMAS from 1990 to 2015. Based on clinical data, all patients were divided into 2 groups. The 1st group consisted of 101 patients aged 3 – 81 (25.8 ± 3.4) years. The obstruction of the duodenum appeared in them 1–53 (8.2±1.9) days after severe stressful events: complicated surgeries, burns, trauma, chemotherapy, etc. In 126 patients of the second group aged 17– 86 (36.7±2.2) years, including 8 patients with anorexia nervosa, the duodenal obstruction occurred after 3 -72 (17.2±3.2) months of the chronic diseases. Almost all these patients had acid related upper gastrointestinal tract diseases. It became apparent that two different processes can lead to the appearance of duodenal obstruction (Table 1).

1st group: Acute development of symptoms was in the stressful conditions, which in the catabolic stage are accompanied by significant weight loss. This is especially often observed in adolescents after surgery on the spine [6,7]. It is known that stress states are accompanied by a decrease in the pH of gastric 10 contents. In such cases, even high doses of proton pump inhibitors do not have an effect in improving gastric pH [13]. Conservative treatment in conditions of partial obstruction of the duodenum was successful in 89% of patients after 2-59 (13.4±2.9) days. Obviously, during this time, neither intravenous hyperalimentation, nor tube introduction of food into the small intestine could change either the total weight of patients or the volume of adipose tissue in the AMA. Moreover, after the restoration of patency in the duodenum, the distance between the vessels does not change [9]. Therefore, the positive effect of conservative treatment is not associated with an increase in adipose tissue in the AMA, which does not support the hypothesis of the role of AMA in the pathogenesis of SMAS.

2nd group: In patients of the 2nd group with functional dyspepsia, postprandial syndrome, and other peptic syndromes, the pathology is due to the hypersecretions of hydrochloric acid. They, in contrast to the patients in the 1st group, had a long history of the disease. Disturbance of the duodenal patency increased gradually: from slight disruption to complete obstruction. In these patients, as Ochsner showed, hypertrophy of the circular muscle layer of the third part of the duodenum distal to the sphincter of Oddi occurs. This may be the reason for the lower effectiveness of the short-term conservative treatment in patients of the 2nd group. As can be seen from Table 1, surgeons operated the patients of the 2nd group, only based on a decrease in AMA (<25), or the distance between the aorta and SMA (< 8 mm). In 47% of cases, the operation was performed without attempting conservative treatment. Conservative treatment was successful in 39% of cases, and in 14% of cases conservative treatment was short-term and ineffective. These patients were operated on. Thus, 61% of patients with peptic problems accompanied by duodenal dyskinesia were operated on only because they were thin or had no effect after short-term non-pathogenic conservative treatment.

How does the AMA change?

This question is very important, since another, even more improbable hypothesis about the role of adipose tissue in AMA has been proposed to support the vascular hypothesis. The diagram in Figure 5 in parts A and B shows the principle of this hypothesis. SMAS supposedly arises from the loss of adipose tissue in the AMA, which leads to compression of the duodenum, which passes through this angle. From this follows the principle of SMAS treatment, i.e., hyperalimentation, to increase the volume of adipose tissue and push the SMA anteriorly and thus make room for the duodenum. This hypothesis is rejected by the following evidence. 1) An increase in soft adipose tissue in the AMA cannot push back a tense vessel. 2) An additional volume of adipose tissue competes with the duodenum for space in the AMA, i.e., it can increase its compression. 3) Hyperalimentation can lead to an increase in adipose tissue only with a simultaneous increase in fat throughout the body. This means that for enough fat to appear in the AMA, the patient must gain tens of kilograms. This cannot be done not only in a few days, but also in many months, especially since we are talking about a violation of the patency of the duodenum. Figure 5 provides further evidence that “when BMI of a patient decreases, there is a corresponding reduction in SMA angle and distance» [14,12].

Etiology, pathogenesis, diagnosis, and treatment of Ochsner`s sphincter dyskinesia.

The above evidence leads to the following conclusions:

1. The zone of contraction in the 3rd part of the duodenum with a length of 2.5-4.6 (3.30 ± 0.15) cm cannot be caused by compression of the intestine in the AMA, firstly, because between the aorta with a diameter of 2 cm and the SMA with a diameter of 0.5 cm, the length of the compressed intestine cannot be more than 1 cm. Secondly, the beginning of the contracted segment of the duodenum is a few centimeters cranial to the AMA. In length (3.2 ± 0.15 cm) and localization, the contracted segment of the duodenum corresponds to the sphincter Ochsner, which normally contracts to prevent an aggressive low pH bolus from entering the small intestine. A prolonged contraction of the sphincter Ochsner, which disrupts the passage into the jejunum, indicates its dyskinesia.

2. Article 8. Neri et al. [8], identifying AMA < 25° and distance between aorta and SMA < 8 mm as proof of SMAS is based on false information and is untrue. These parameters are proportional to BMI. Surgeons relying on these parameters operate on patients with dyspepsia, duodenitis or duodenal ulcer without signs of obstruction. They produce a bypass duodenojejunostomy, because of which the aggressive chyme immediately from the stomach enters the jejunum, which inevitably leads to chronic enteritis.

3. The notion that the cause of SMAS is the loss of adipose tissue in the AMA and hyperalimentation over several weeks can lead to fat accumulation in AMA and to recovery does not withstand scientific scrutiny.

Etiology

Hypersecretion of hydrochloric acid provokes by the food ingredients. These provocateurs or stimuli includes delayedonset diseases, that can be mediated by intestinal mucosal mechanisms involving not only IgE but also T cells, mast cells and eosinophils that produce proinflammatory mediators. Belong of this kind of disease: atopic dermatitis, celiac disease, or eosinophilic GI diseases, such as esophagitis, gastritis, gastroenteritis, enterocolitis and proctitis” [15]. It turned out that under stress “mast cells (MC) are important effectors of brain-gut axis that translate the stress signals into the release of a wide range of neurotransmitters and proinflammatory cytokines, which may profoundly affect the gastrointestinal physiology” [16]. In both cases, one of the end products is acid hypersecretion. The lactose is the most common provocateur of hydrochloric acid hypersecretion [17]. It causes the release of histamine from mast cells, which, through a chain of mediators, leads to the hypersecretion of hydrochloric acid. There are patients with histamine intolerance [18] and others. Thus, the hypersecretion of hydrochloric acid is the cause of all acid-dependent diseases (esophagitis, GERD, stomach ulcer and gastritis, duodenal ulcer and duodenitis, sphincter of Oddi dyskinesia and cholecystitis, as well as SMAS). As a rule, one of these problems, to a greater or lesser extent, are present in every patient with Ochsner’s sphincter dyskinesia.

Pathogenesis

Prolonged duodenal irritation with low pH hydrochloric acid causes an increase in the tone of Ochsner’s sphincter, which gradually leads to wall hypertrophy, as Ochsner saw during the operation. If normally a fleeting contraction of the sphincter Ochsner is recorded as a pendulum movement of the bolus, then with dyskinesia, a narrowing of the intestine is clearly recorded. However, it is necessary to distinguish between the contraction of the sphincter Ochsner without disturbing the bolus evacuation into the jejunum with obstruction of the duodenum, which is characterized by the expansion of the stomach and duodenum and is accompanied by vomiting.

Diagnosis

As shown above, the magnitude of the AMA and the distance between the aorta and the SMA are proportional to the BMI. This means that a decrease in these parameters only indicates the thinness of patients. Therefore, their definition on CT, MRI and US does not make any sense. Two clinical conditions must be distinguished: (a) For symptoms of intestinal obstruction that are accompanied by recurring vomiting, a radiography is shown to determine the size of the stomach and duodenum. (b) Abdominal pain, weight loss, and other symptoms of acid-related disease require a barium x-ray. If sphincter Ochsner dyskinesia is detected, gastroscopy should be the next step to rule out tumor, peptic stenosis, and other acid-related disorders.

Treatment

Based on our hypothesis, dyskinesia of the sphincter Ochsner is caused by hypersecretion of hydrochloric acid and the pathogenetic treatment should be aimed at the reducing of the hydrochloric acid release and removing it from the duodenum. As the literature analysis has shown, the most effective are nasogastric decompression with nasojejunal feeding. In patients without obstruction of the duodenum, the use of PPI 40 mg twice a day for 4 weeks is justified. In patients with obstruction of the duodenum The high-dose PPI therapy (intravenous loading dose followed by continuous infusion) [19,20] until the sphincter Ochsner is fully opened, followed by a transition to oral PPI reception.

The duodenal irrigation with alkaline solution is theoretically justified. In the absence of the effect of drug treatment to relieve spasm of the sphincter Ochsner, the use of Botox injections is justified. With sphincter Ochsner dyskinesia, there is no place for surgical treatment.

REFERENCES
  1. Levin MD, Korshun Z, Mendelson G. [Duodenal motility in norm and in some diseases. Hypothesis]. Ter Arkh. 2016: 88; 68-74.
  2. van Beek AP, Emous M, Laville M, J Tack J. Dumping syndrome after esophageal, gastric or bariatric surgery: pathophysiology, diagnosis, and management. Obes Rev. 2017: 18; 68-85.
  3. Levin MD. Ochsner’s Sphincter Dyskinesia Is the Cause of Superior Mesenteric Artery Syndrome. J Gastrointest Surg. 2019: 23; 1714- 1716.
  4. Ochsner AJ. VIII. Construction of the Duodenum Below the Entrance of the Common Duct and Its Relation to Disease. Ann Surg. 1906; 43; 80-87.
  5. Aldot G, Kapandji M, Ringendach J. Physiology of timed duodenal intubation. II. Role of Ochsner’s sphincter in the mechanism of normal duodenal intubation and in that of certain prolongations of so-called 13 Oddi’s closed time. Arch Mal Appar Dig Mal Nutr. 1956; 45: 449-57.
  6. Levin MD. Sphincter Ochsner dyskinesia as a cause of superior mesenteric artery syndrome. Review. Vestn Rentgenol Radiol. 2016; 97: 110-117.
  7. Levin MD. PATHOGENETIC SIGNIFICANCE OF DYSKINESIA OF THE SPHINCTER OF OKSNER IN THE DEVELOPMENT OF THE SYNDROME OF THE SUPERIOR MESENTERIC ARTERY. Review. Eksp Klin Gastroenterol. 2016; 12: 67-72.
  8. Biank V, Werlin S. Superior mesenteric artery syndrome in children: a 20- year experience. J Pediatr Gastroenterol Nutr. 2006; 42: 522-25.
  9. Santer R, C Young C, Rossi T, Riddlesberger MM. Computed tomography in superior mesenteric artery syndrome.Pediatr Radiol. 1991; 21: 154-155.
  10. Neri S, Signorelli SS, Mondati E, D Pulvirenti, E Campanile, L Di Pino, et al. Ultrasound imaging in diagnosis of superior mesenteric artery syndrome. J Intern Med. 2005; 257: 346-351.
  11. Diagnostic imaging in internal medicine. By R.L. Eisenberg. Copyright© 1985 by McGraw-Hill, Inc. 694.
  12. Bhagirath Desai A, Sandeep Shah D, Jagat Bhatt C, Kavita UV, B Salvi, et al. Measurement of the Distance and Angle Between the Aorta and Superior Mesenteric Artery on CTScan: Values in Indian Population in Different B MI Categories. Indian J Surg. 2015; 77: 614-617.
  13. Lenz K, Buder R, Fir linger F, Lohr G, Voglmayr M. Effect of proton pump inhibitors on gastric pH in patients exposed to severe stress. Wien Klin Wochenschr. 2014; 127: 51-56.
  14. Alzerwi NAN. Predictors of Superior Mesenteric Artery Syndrome: Evidence from a Case-Control Study. Cureus. 2020; 12: e9715.
  15. Cuomo R, Andreozzi P, Zito FP, V Passananti, GD Carlo, G Sarnelli. Irritable bowel syndrome and food interaction. World J Gastroenterol. 2014; 20: 8837-8845.
  16. Konturek PC, Brzozowski T, Konturek SJ. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options. J Physiol Pharmacol. 2011; 62: 591-599.
  17. Minenna MF, Palieri A, Panella C, Ierardi E. Gastro-oesophageal reflux disease and lactose malabsorption: Casual comorbidity or neglected association? Dig Liver Dis. 2006; 38: 437-438.
  18. Comas-Basté O, Sánchez-Pérez S, Veciana-Nogués MT, M LatorreMoratalla, MDC Vidal-Caron. Histamine Intolerance: The Current State of the Art. Biomolecules. 2020; 10: 1181.
  19. Barkun AN, Almadi M, Kuipers EJ, Loren L, Joseph S, Frances T, et al. Management of Nonvariceal Upper Gastrointestinal Bleeding: Guideline Recommendations From the International Consensus Group. Ann Intern Med. 2019; 171: 805-822.
  20. Pang SH, Graham DY. A clinical guide to using intravenous protonpump inhibitors in reflux and peptic ulcers. Therap Adv Gastroenterol. 2010; 3: 11-22.
Received : 12 Jun 2023
Accepted : 30 May 2023
Published : 30 May 2023
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X